Search for Clinical Trial Results
Abdominal Neoplasms - 350 Studies Found
Status | Study |
Completed |
Study Name: Comparison of Hemodynamics Between Dexmedetomidine and Propofol for Sedation in Patients With Abdominal Surgery Condition:
Interventions: |
Not yet recruiting |
Study Name: EDMONd - Elemental Diet in Bowel Obstruction Condition:
Interventions: Dietary Supplement: Elemental 028 Extra Liquid A nutritionally complete, liquid elemental diet consistin |
Completed |
Study Name: Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery Condition:
Date: 2015-01-29 Interventions:
|
Active, not recruiting |
Study Name: Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condition:
|
Completed |
Study Name: Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy Condition:
|
Withdrawn |
Study Name: A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer Condition: Ovarian, Fallopian Tube and Peritoneal Cancer Date: 2014-10-27 Interventions:
|
Recruiting |
Study Name: AZD1775 Plus Chemotherapy in Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condition: Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation Date: 2014-10-14 Interventions:
|
Recruiting |
Study Name: "Re-Stimulated" Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy in Patients With Platinum Resistant High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condition: Recurrent, Platinum Resistant High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Date: 2013-06-11 Interventions:
|
Terminated |
Study Name: Abraxane/Bevacizumab Condition:
Date: 2013-03-27 Interventions:
|
Recruiting |
Study Name: An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA) Condition: Peritoneal Neoplasms Date: 2012-09-28 |